News Snapshot:
FDA approves Chinese drug Lian Hua Qing Wen for mild COVID-19 Maris Federez • August 13, 2020 • 9 MANILA, Philippines — The Food and Drug Administration (FDA) has approved a traditional Chinese drug for the treatment of mild coronavirus disease 2019 (COVID-19). According to the Certificate of Product Registration released by the FDA, Lian Hua Qing Wen “has been found to conform with the requirements and standards for marketing authorization for pharmaceutical products per existing regulations in force as of date hereof.†Lian Hua Qing Wen, produced by traditional Chinese medicine manufacturer Shijiazhuang Yiling Pharmaceutical Co. Ltd., was approved...
